Source: International Congress 2016 – Asthma points to ponder
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ayşe Arzu Yorgancıoğlu (Izmir, Turkey), Ayse Arzu Yorgancioglu, Ferda Öner Erkekol, Münevver Erdinç, Dilsad Mungan, Bilun Gemicioglu, Zeynep Ferhan Özseker, Papatya Bayrak Degirmenci, Sibel Nayci, Aykut Çilli, Füsun Erdenen, Cengiz Kirmaz, Dane Ediger, Arzu Didem Yalçin, Suna Büyüköztürk, Sami Büyüköztürk, Mustafa Güleç, Rana Isik, Ali Fuat Kalyoncu, Özlem Göksel, Ömür Aydin, Yavuz Havlucu, Idilhan Baloglu Ar, Ahmet Erdogdu. Effectiveness evaluation of anti-IgE treatment at 3rd year: Real life Turkey data. Eur Respir J 2016; 48: Suppl. 60, 3381

Member's Comments

No comment yet.

Related content which might interest you: The control of asthma in real life: Baseline evaluation of a long-term study Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016 Real-world outcomes in patients receiving omalizumab for allergic asthma in India: Analysis by baseline IgE level Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Outcomes with omalizumab in Indian patients with allergic (IgE-mediated) asthma: Results at 16 and 28 weeks Source: Annual Congress 2013 –Treatment of asthma Year: 2013 Bronchial thermoplasty in patients with very severe asthma: Safety and clinical outcomes Source: International Congress 2016 – Airway stenting and ablation Year: 2016 P-PiXel: A ’real-life’ evaluation of omalizumab use in asthmatic patients Source: International Congress 2016 – Asthma management Year: 2016 Global evaluation of treatment effectiveness (GETE) is an accurate predictor of response to omalizumab in patients with severe allergic asthma: A pooled analysis Source: International Congress 2014 – Intervening in allergic asthma Year: 2014 Evaluation of omalizumab therapy in a Chinese versus predominantly Caucasian population: Comparison of clinical data Source: International Congress 2015 – Immune mechanisms in the human lung Year: 2015 The change of asthma course during pregnancy Source: International Congress 2015 – Prevalence of respiratory disease Year: 2015 Effects of Xolair® in children: The X-HALE study Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013 Health related quality of life in asthmatic subjects after 3 months treatment with inhaled corticosteroids Source: International Congress 2015 – Co-existing diseases and asthma Year: 2015 Fluticasone propionate/formoterol therapy for asthmatic patients: Results of a non-interventional study Source: International Congress 2016 – Asthma management Year: 2016 Late Breaking Abstract - Comparative analysis of effectiveness of Asthma Control Test-guided treatment versus usual care in patients with asthma from China Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Effectiveness of montelukast on asthma control in infants: A claims data study Source: International Congress 2015 – Treatment and control of respiratory disease Year: 2015 International perspectives on severe asthma: Current and future challenges in patient care Source: International Congress 2016 – Asthma points to ponder Year: 2016 Preferences of patients with asthma and COPD for components of inpatient pneumological rehabilitation: A discrete choice experiment Source: International Congress 2016 – Latest insights into chronic care Year: 2016 Detection of asthma patient-reported exacerbations during follow-up in the ASTROLAB cohort Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015 Quality of life and asthma control in elderly asthmatics: A seven year follow-up – Results from the PRAXIS study Source: International Congress 2016 – Asthma management in primary care Year: 2016 Real life experience of omalizumab on selected children with severe allergic asthma Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016 Risk for adverse outcomes in asthma: Assess to impress! Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 Effectiveness of omalizumab in Greek patients with severe allergic asthma (SAA): The SMILE study Source: International Congress 2016 – Asthma points to ponder Year: 2016